The American Society of Cataract and Refractive Surgery will form a task force to review the COMPASS-XT study data that recently led to a voluntary recall of Alcon’s CyPass micro-stent.
ASCRS Clinical Committee leaders who specialize in glaucoma and cornea will make up the task force, which will conduct an independent evaluation of the data, according to a press release.
“ASCRS takes seriously its responsibility to empower its members to provide the absolute best surgical care,” ASCRS President Thomas W. Samuelson, MD, said in the release. “With clinical committees in
Uncategorized